Clinical trials
Recruiting Diabetes Mellitus, Type 2 trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 6 |
| National Taiwan University Hospital | 3 |
| Eli Lilly and Company | 2 |
| Bayer | 1 |
| Boehringer Ingelheim | 1 |
| China Medical University Hospital | 1 |
| Hoffmann-La Roche | 1 |
| Novo Nordisk A/S | 1 |
| Taichung Veterans General Hospital | 1 |
| Taipei Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 19 |
| Obesity | 4 |
| Overweight | 3 |
| Diabetes Mellitus | 2 |
| Hypertension | 2 |
| Renal Insufficiency, Chronic | 2 |
| Cardiovascular Diseases | 1 |
| Diabetes Complications | 1 |
| Diabetic Nephropathies | 1 |
| Diabetic Retinopathy | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.